
Invest-NL has committed to Keen Venture Partners’ European Defence & Security Tech Fund.

Chris Wade shares his perspective on the industry, explains how secondary transactions are reshaping LP liquidity, and offers practical advice for fund managers.

The fresh capital will be used to expand production capacity and strengthen Fasal Bio’s commercial and R&D teams.